Navigation Links
Genstar Capital Promotes J. Ryan Clark to Principal
Date:2/11/2008

SAN FRANCISCO, Feb. 11 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences and healthcare services, industrial technology, business services and software services, today announced that it has promoted J. Ryan Clark to Principal. Mr. Clark joined Genstar in 2004 and serves on the Boards of several Genstar portfolio companies, including Panolam Industries International, Inc., Fort Dearborn Company, PRA International, 21st Services, and Confie Seguros, the firm's most recent investment.

"Our people are the difference in our investments and as we continue to succeed in growing our portfolio of companies we are pleased to honor and recognize the achievements of our strong team of investment professionals," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "Ryan has contributed greatly to a number of our key investments since he joined the firm and has been instrumental in building out our information and insurance services practice. All of us at Genstar congratulate him and look forward to working him for many years."

Prior to joining Genstar, Ryan was an Associate at Hellman & Friedman LLC, a private equity investment firm. Previously, he worked in the Mergers, Acquisitions and Restructuring Department at Morgan Stanley in New York. Ryan earned an MBA from the Harvard Business School, and an AB in Environmental Science and Public Policy from Harvard College.

Mr. Clark will continue to develop investment opportunities in the information and insurance services industries and has led the firm's investment in 21st Services, a Minneapolis-based company that provides life expectancy information used in the life settlement industry, and also Confie Seguros, a platform company to consolidate insurance brokerages primarily focused on the Hispanic consumer.

About Genstar Capital, LLC

Genstar Capital (http://www.gencap.com) is a leading private equity firm that for 20 years has been actively investing in high quality middle-market companies and building value in those businesses by utilizing the expertise of its operating partners. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating partners and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, industrial technology, software, and business services industries.

Contact: Chris Tofalli

Chris Tofalli Public Relations

914-834-4334


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genstar Capital Appoints Mark Hanson to Managing Director
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. AtriCure to Present at Roth Capital Partners 2007 New York Conference
4. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
5. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Advanced Life Sciences Joins NASDAQ Capital Market
10. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
11. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading ... has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE ... Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage Lung ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... Suite 10.2 version gives development continuity to its innovative Unified Instance Manager ... management capacity. In addition, this new version optimizes the unattended auto-dialing system ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged to ... mind, SIGVARIS has created a new line of anti-embolism stockings to help prevent ... the benefits of graduated compression when transitioning from recovery to early rehabilitation. , ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... from offices headquartered in Jefferson County, is announcing the launch of a charity ... , The number of homeless women and children in Birmingham has grown steadily ...
(Date:12/8/2016)... ... December 08, 2016 , ... Bill Mull Agencies, a Wichita-based ... and around central Kansas, is joining the Youth Horizons organization for a charity ... Headquartered in Wichita, Youth Horizons works to empower area children from unstable, troubled, ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... -- Economic growth in the United States will continue in ... in their December 2016 Semiannual Economic Forecast. Expectations are ... in mid-2009, as indicated in the monthly ISM ® ... manufacturing sector is optimistic about growth in 2017, with ... the non-manufacturing sector indicates that 14 of its industries ...
(Date:12/8/2016)... LOS ANGELES , Dec. 8, 2016 /PRNewswire/ ... and manufacturing of dissolution testing and diffusion testing ... has been acquired by Teledyne Instruments, Inc. ("Teledyne"). ... Hanson,s long-proven line of precision testing instruments, as ... while accelerating development of new products and services. ...
Breaking Medicine Technology: